Clinical trial
Bumetanide in Patients With Alzheimer's Disease
NCT06052163
Study timeline
Study start (actual)2023-04-10Date precision: day
Registry last updated2026-01-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer Diseaseunresolved
Interventions
BumetanideDRUG · verified · RxNorm: bumetanide
PlaceboDRUG
Sponsors & collaborators
Stanford Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06052163 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.